Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrave for Weight Maintenance (COR-WM)
NCT04589130Phase 4Unknown
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in obesity, Overweight, sponsored by St. Joseph's Healthcare Hamilton. Status: unknown.
02
Drugs
naltrexone + bupropion
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT04589130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589130.